The new lung cancer screening program needs to be independently evaluated to keep it on track, and to minimise the harms.

A new treatment option, Datroway (datopotamab deruxtecan or Dato-DXd), is now available for people with non-small cell lung ...

Nearly a quarter of all newly-diagnosed patients with advanced lung cancer are not given a test that could improve their chances for long-term survival and reduce their side effects.

Northwestern’s iSeg tool matches expert doctors and finds hidden cancer zones, with clinical rollout expected soon.

Trained on multi-hospital data, iSeg spots moving tumors doctors sometimes miss, edging radiation treatment toward pinpoint ...

During June, investigators reported new data that has advanced the treatment landscape for lung cancer, including new FDA ...

From July, eligible Australians will be screened for lung cancer as part of the nation's first new cancer screening program ...

Dizal will market sunvozertinib in the US under the Zegfrovy brand name, entering a market for EGFR inhibitors currently dominated by AstraZeneca's Tagrisso (osimertinib) but currently being shaken up ...

Regular screening can bend the odds in your favor when it comes to four types of cancers. The science is less clear for the ...

Researchers at McMaster University, Cleveland Clinic and Case Comprehensive Cancer Center have uncovered how a protein long ...

Researchers at McMaster University, Cleveland Clinic and Case Comprehensive Cancer Center have uncovered how a protein long ...